Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Can you name the bacteria primarily targeted by tigecycline?

See the DrugPatentWatch profile for tigecycline

Which bacteria does tigecycline primarily target?

Tigecycline is designed to target a range of bacteria, with particular focus on multi-drug resistant organisms. The bacteria it is primarily used against include:

- Methicillin-resistant Staphylococcus aureus (MRSA)
- Vancomycin-resistant Enterococcus (VRE)
- Resistant Streptococcus species (including some cases involving resistance patterns seen in clinical settings)
- Extended-spectrum beta-lactamase (ESBL)-producing Gram-negative bacteria
- Carbapenem-resistant Gram-negative bacteria

Tigecycline’s spectrum also includes other common hospital-associated infections caused by susceptible Gram-positive and Gram-negative bacteria, but it is most noted for activity against resistant strains listed above.



Other Questions About Tigecycline :

How does tigecycline's impact on alt differ from other antibiotics? How did tigecycline's patent delay generic alternatives? How do antacids impact tigecycline's serum concentrations? What are the success rates of tigecycline in treating anaerobic infections? What's the impact of ph changes by antacids on tigecycline? How significantly does tigecycline overuse affect survival odds in certain conditions? Is severe infection prognosis impacted by tigecycline overdose?